Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network
Authors
Zaidi, Sayyed K.Dowdy, Christopher R.
Van Wijnen, Andre J.
Lian, Jane B.
Raza, Azra
Stein, Janet L.
Croce, Carlo M.
Stein, Gary S.
UMass Chan Affiliations
Department of Cell BiologyDocument Type
Journal ArticlePublication Date
2009-10-15Keywords
Cell ProliferationCell Differentiation
Leukemia, Myeloid, Acute
Core Binding Factor Alpha 2 Subunit
Humans
MicroRNAs
Transcription Factors
Mitogen-Activated Protein Kinase Phosphatases
Cell Biology
Metadata
Show full item recordAbstract
Disruption of Runx1/AML1 subnuclear localization, either by a single amino acid substitution or by a chromosomal translocation [e.g., t(8;21)], is linked to the etiology of acute myeloid leukemia (AML). Here, we show that this defect induces a select set of micro-RNAs (miR) in myeloid progenitor cells and AML patients with t(8;21). Both Runx1 and the t(8;21)-encoded AML1-ETO occupy the miR-24-23-27 locus and reciprocally control miR-24 transcription. miR-24 directly downregulates mitogen-activated protein kinase (MAPK) phosphatase-7 and enhances phosphorylation of both c-jun-NH(2)-kinase and p38 kinases. Expression of miR-24 stimulates myeloid cell growth, renders proliferation independent of interleukin-3, and blocks granulocytic differentiation. Thus, compromised Runx1 function induces a miR-dependent mechanism that, through MAPK signaling, enhances myeloid proliferation but blocks differentiation--key steps that contribute to leukemia.Source
Cancer Res. 2009 Nov 1;69(21):8249-55. Epub 2009 Oct 13. Link to article on publisher's siteDOI
10.1158/0008-5472.CAN-09-1567Permanent Link to this Item
http://hdl.handle.net/20.500.14038/26580PubMed ID
19826043Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1158/0008-5472.CAN-09-1567